The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

在报告调查的特效药中，有22%的药品都存在这种程度的加价，包括用于治疗白血病的仿制药伊马替尼（Imatinib）或用于肺动脉高压的非肿瘤药物他达拉非（Tadalafil）等。HIV阳性患者需要的拉米夫定（Lamivudine）等药品的价格几乎是其采购成本的四倍。

After almost seven decades of providing medication and more to the people of San Angelo, Medical Arts Pharmacy is shutting ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.